Hashimoto's thyroiditis associated with acquired idiopathic demyelinating polyradiculoneuropathy Sir, Simultaneous presentation of acquired idiopathic demyelinating polyradiculoneuropathy (IDP) and Hashimoto's thyroiditis suggests that IDP has an autoimmune pathogenesis.
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A 51 year old man presented with a 5-week history of weakness, initially in the legs and progressing to involve the arms. No recent viral infection or immunization had occurred. Two weeks before admission he had seen his general practitioner for the leg weakness and tiredness but had no other symptoms of hypothyroidism. At that time, thyroid stimulating hormone was raised (34.8 mU/l, normal range 0.4-6.0) and free thyroxine was within normal limits (10.4 pmol/l, normal range 8.8-23). There was no family history of thyroid or neurological disease and previously he had been healthy except for mild hypertension treated with atenolol. Thyroxine 50 jig/day was commenced one week prior to hospital admission but his weakness progressed. On examination, the cranial nerves were normal. The limbs displayed symmetrical, distally predominant weakness affecting the legs more than the arms, with areflexia and flexor plantar responses. He was unable to stand unaided. Light touch and pain sensation were decreased on the anterior aspects of both thighs. Forced vital capacity was 3. nerves. Routine haematological and biochemical parameters were normal. Autoantibodies were found against thyroglobulin (titre > 1: 5120) and thyroid microsomes (strongly positive). Antibodies against parietal cells, mitochondria, smooth muscle cells, reticulin and nuclei were absent. He was treated with prednisolone 60 mg/day and after 6 days the strength of his hands improved. Three months later he became able to walk 5 m without aid and has continued to improve whilst slowly decreasing the prednisolone. Four months after the onset he had not relapsed.
The clinical and neurophysiological picture and CSF results supported the diagnosis of an acquired IDP. The initial 5-week history of progressive weakness suggested a subacute form of acquired IDP rather than Guillain-Barre syndrome.' The occurrence of hypothyroidism with a high titre of antibodies to thyroid tissue is pathognomonic of Hashimoto's thyroiditis.2 There has been one previous report of an association between 'autoimmune' hypothyroidism and chronic IDP,3 and three reports of hypothyroidism and Guillain-Barre syndrome. [4] [5] [6] Simon A. Koblar Department of Neurology, Guy's Hospital, London SE] 9RT, UK.
